Hereditary blindness caused by a progressive degeneration of the light-sensing cells in the eye, the photoreceptors, affects millions of people worldwide.
Although the light-sensing cells are lost, cells in deeper layers of the retina, which normally cannot sense light, remain intact. A promising new therapeutic approach based on a technology termed “optogenetics” is to introduce light-sensing proteins into these surviving retinal cells, turning them into “replacement photoreceptors” and thereby restoring vision. However, several factors limit the feasibility of a clinical optogenetic therapy using traditional light-sensitive proteins, as they require unnaturally high and potentially harmful light intensities and employ a foreign signaling mechanism within the target retinal cells.
New research publishing May 7th in the Open Access journal PLOS Biology from van Wyk and colleagues demonstrates how optogenetic proteins can be tailored to bring this promising technology closer to medical application. “We were asking the question, ‘Can we design light-activatable proteins that gate specific signaling pathways in specific cells?’, in other words, can the natural signaling pathways of the target cells be retained and just modified in a way to be turned on by light instead of a neurotransmitter released from a preceding neuron?” says Dr. Sonja Kleinlogel, corresponding author of the paper (whose research group is based at the University of Berne, Switzerland). The aim of molecular engineering was to achieve maximal compatibility with native signaling whilst retaining all the advantages of traditional optogenetic proteins, such as fast kinetics and resistance to bleaching by light.
The novel light-sensing protein, termed Opto-mGluR6, is a chimeric protein composed of the light-sensing domains of the retinal photopigment melanopsin and the ON-bipolar cell-specific metabotropic glutamate receptor mGluR6, which is naturally activated by glutamate released from the photoreceptors and amplifies the incoming signal through a coupled intracellular enzymatic pathway. Unlike rhodopsin, for example, the “light antenna” of melanopsin is resistant to bleaching. In other words, the response strength of Opto-mGluR6 never attenuates, no matter how often and hard the protein is hit by light. Moreover, since Opto-mGluR6 is a chimeric protein consisting of two “local” retinal proteins it is also likely to be “invisible” to the immune system, another improvement over traditional optogenetic proteins.
In their study van Wyk and colleagues targeted the retinal ON-bipolar cells, which naturally receive direct input from the photoreceptors. Targeting the surviving cells at the top end of the visual cascade has the advantage that signal computation of the retina is maximally utilized. Turning the native chemical receptor (mGluR6) into a light-activated receptor ensures conservation of native signaling within the ON-bipolar cells, conferring high light-sensitivity and fast “normal” responsiveness. In their study they show proof-of-principle that mice suffering from Retinitis pigmentosa can be treated to regain daylight vision. “The new therapy can potentially restore sight in patients suffering from any kind of photoreceptor degeneration” says Dr. Kleinlogel, “for example also those suffering from severe forms of age-related macular degeneration, a very common disease that affects to some degree about one in every 10 people over the age of 65”.
“The major improvement of the new approach is that patients will be able to see under normal daylight conditions without the need for light intensifiers or image converter goggles”
The Latest on: Optogenetics
via Google News
The Latest on: Optogenetics
- An electronic chip that makes ‘memories’on July 21, 2019 at 7:32 am
To develop this, we drew inspiration from a new technique called optogenetics, to develop a device that replicates the way the brain stores (and loses) information. Optogenetics involves using ... […]
- Literal Window into the Brain Shows How to Induce Illusions in Miceon July 19, 2019 at 6:36 am
The researchers used a technique called optogenetics to stimulate individual neurons in the visual cortex of mice, and induce an illusory image. They were surprised that stimulating just 20 or ... […]
- Scientists Use Lasers To Induce Hallucinations In Mice – What Could Go Wrong?on July 19, 2019 at 5:03 am
Optogenetics involves making brain cells produce light-sensitive proteins and stimulating them with pulses of light. Using infrared lasers Professor Karl Deisseroth of Stanford University has made it ... […]
- Laser holograms stimulate brain cells in mice to probe roots of perception and hallucinationon July 18, 2019 at 11:37 am
Two teams, however, have recently adapted optogenetics—a technology for stimulating neurons with light—to precisely awaken particular cells in the visual cortex of a mouse. They showed that zapping ... […]
- Manipulating nerve cells makes mice ‘see’ something that’s not thereon July 18, 2019 at 11:04 am
The experiment used optogenetics, a technique in which laser light activates neurons in the brain (SN: 1/30/10, p. 18). The neurons are genetically tweaked to carry a protein that prompts them to send ... […]
- Warren Alpert Award goes to four scientists for seminal discoveries in optogeneticson July 17, 2019 at 7:25 am
The 2019 Warren Alpert Foundation Prize has been awarded to four scientists for pioneering work in the field of optogenetics, a revolutionary technique that uses light and genetic modification to ... […]
- Optogenetics pioneers win prestigious medical research awardon July 17, 2019 at 4:21 am
Four of the world’s leading exponents of optogenetics - the use of light to monitor and stimulate brain cells - have won the 2019 Warren Alpert Foundation Prize for medical research. The award, often ... […]
- Electronic chip mimics the brain to make memories in a flashon July 17, 2019 at 4:10 am
Researchers from RMIT University have drawn inspiration from optogenetics, an emerging tool in biotechnology, to develop a device that replicates the way the brain stores and loses information. ... […]
- Optogenetics Market Research Insights 2019 Trends, Technology Growth To Procure a Stronge Industry Share till 2023on June 26, 2019 at 8:05 am
Optogenetics is a technique that enables scientists to control the brain. It is done by controlling the signaling of individual neurons. The technique combines methods from genetics and optics to ... […]
- Global Optogenetics Market Outlook to 2024 - Light Emitting Diode (LED) Light Equipment is Expected to Observe Fast Growthon June 23, 2019 at 5:00 pm
Dublin, June 24, 2019 (GLOBE NEWSWIRE) -- The "Global Optogenetics Market Outlook to 2024" report has been added to ResearchAndMarkets.com's offering. The major factors for the growth of the ... […]
via Bing News